下列文章都是我和我的同事过去多年来所发表的英文论文,有些论文在此无法提供原文。新论文发表之后我将随时更新,网上拿到全文后也将及时补上。
1. Infiltration of eosinophils into the asthmatic airways caused by interleukin 5. Am J Respir Cell Mol Biol 1997; 16: 220-224. 2. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics. Am J Respir Crit Care Med 1998; 157: 204-209. 3. Effect of thromboxane A2 inhibitors on allergic pulmonary inflammation in mice. Eur Respir J 1998; 11: 624-629. 4. Effect of inhaled interleukin-4 on airway hyperreactivity in asthmatics. Am J Respir Crit Care Med 1998; 157: 1818-1821. 5. Effect of inhaled interleukin-5 on number and activity of eosinophils in circulation from asthmatics. Clin Immunol 1999; 91: 163-169. 6. Inhaled IL-5 increases concentrations of soluble intracellular adhesion molecule-1 in sputum from atopic asthmatic subjects. J Allergy Clin Immunol 1999; 103: 463-467. 7. Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest 2000; 105: 945-953. 8. Endobronchial eosinophils preferentially stimulate T helper cell type 2 responses. Allergy 2004; 59: 428-435. 9. Eosinophils in asthma. Chin Med J 2004; 117: 792-794. 10. Eosinophils function as antigen-presenting cells. J Leukoc Biol, 2004; 76: 520-527. 11. Soluble CD86 protein in serum samples of patients with asthma. Thorax 2004; 59: 870-875. 12. Regulatory CD4+CD25+ T lymphocytes in peripheral blood from patients with atopic asthma. Clin Immunol 2004; 113: 172-178. 13. Effects of antigen presentation of eosinophils on lung Th1/Th2 imbalance. Chin Med J 2005, 118: 6-11. 14. Interleukin-16 in tuberculous and malignant pleural effusions. Eur Respir J 2005; 25: 605-611. 15. Soluble CTLA-4 in sera of patients with bronchial asthma. J Asthma 2005; 42: 133-139. 16. DNA vaccine and asthma therapy. Chin Med J 2005; 118: 531-533. 17. Effects of allergen inhalation and oral glucocorticoid on serum soluble CTLA-4 in allergic asthmatics. Allergy 2005; 60: 774-779. 18. Effects of allergen inhalation and oral glucocorticoid on concentrations of serum soluble CD86 in allergic asthmatics. Clin Immunol 2005; 115: 178-183. 19. CD4+CD25+ regulatory T lymphocytes in allergy and asthma. Allergy 2005; 60: 986-995. 20. CD4+CD25+ regulatory T lymphocytes in malignant pleural effusion. Am J Respir Crit Care Med 2005; 172: 1434-1439. 21. CD28/CTLA-4-CD80/CD86 and ICOS-B7RP-1 costimulatory pathway in bronchial asthma. Allergy 2006; 61: 15-26. 22. Interleukin16 in asthma. Chin Med J 2006; 119: 1017-1025. 23. Increase in concentration of soluble CD86 after segmental allergen challenge in patients with allergic asthma. Chest 2006; 130: 1048-1054. 24. Major causes of death during the past 25 years in China. Chin Med J 2007; 120: 2317-2320. 25. Diagnostic value of interferon-γ in tuberculous pleurisy: a metaanalysis. Chest 2007; 131: 1133-1141. 26. Diagnostic accuracy of tumor markers for malignant pleural effusion: a meta-analysis. Thorax 2008; 63: 35-41. 27. Diagnostic precision of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respir Med 2008; 102: 744-754. 28. CD4+CD25+ regulatory T lymphocytes in tuberculous pleural effusion. Chin Med J 2008; 121: 581-586. 29. T lymphocytes in pleural effusion. Chin Med J 2008; 121: 579-580. 30. Prognostic significance of pleural lavage cytology in patients with lung cancer: a meta-analysis. Lung Cancer 2008; 60: 183-192. 31. Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a meta-analysis. Respirology 2008; 13: 518-527. 32. expression_r_r_of soluble triggering receptor expression_r_r_on myeloid cells-1 in pleural effusion. Chin Med J 2008; 121: 1656-1661.
33. CCL22 recruits CD4-positive CD25-positive regulatory T cells into malignant pleural effusion. Clin Cancer Res 2009; 15: 2231-2237. 34. Epithelial neutrophil-activating peptide-78 induces neutrophil chemotaxis and degranulation in infectious pleural effusion. Eur Respir J 2009; 34: 184-190.
35. Efficacy of intensified chemotherapy with hematopoietic progenitors in small-cell lung cancer: a meta-analysis of the published literature. Lung Cancer 2009; 65: 214-218.
36. Therapeutic potential of antibodies against interleukin 5 in asthma. Chin Med J 2009; 122: 1363-1364.